SEC 13F Intelligence

Dodge & Cox / GILD

Dodge & Cox’s Gilead Sciences Inc Position

Does Dodge & Cox own Gilead Sciences Inc (GILD)? Yes — 24.25M shares worth $3.4B (+1.86% of its 13F portfolio) as of Q1 2026, down from 26.28M shares the prior filed quarter.

Position Value
$3.4B
Q1 2026
Shares
24.25M
% of Portfolio
+1.86%
Quarters Held
30
currently held

Position History GILD

Reported value by quarter
Q4 ’18: $1.0BQ4 ’18Q1 ’19: $1.1BQ2 ’19: $1.2BQ3 ’19: $1.1BQ4 ’19: $1.1BQ4 ’19Q1 ’20: $1.1BQ2 ’20: $969MQ3 ’20: $797MQ4 ’20: $997MQ4 ’20Q1 ’21: $1.2BQ2 ’21: $2.0BQ3 ’21: $2.6BQ4 ’21: $2.7BQ4 ’21Q1 ’22: $2.2BQ2 ’22: $2.3BQ3 ’22: $2.2BQ4 ’22: $3.1BQ4 ’22Q1 ’23: $2.9BQ2 ’23: $2.6BQ3 ’23: $2.5BQ4 ’23: $2.7BQ4 ’23Q1 ’24: $2.4BQ2 ’24: $2.3BQ3 ’24: $2.8BQ4 ’24: $3.0BQ4 ’24Q1 ’25: $3.7BQ2 ’25: $3.4BQ3 ’25: $3.3BQ4 ’25: $3.2BQ4 ’25Q1 ’26: $3.4Bfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202624.25M$3.4B+1.86%
Q4 202526.28M$3.2B+1.74%
Q3 202530.13M$3.3B+1.80%
Q2 202530.82M$3.4B+1.92%
Q1 202532.69M$3.7B+2.09%
Q4 202432.95M$3.0B+1.77%
Q3 202433.05M$2.8B+1.57%
Q2 202433.12M$2.3B+1.36%
Q1 202433.17M$2.4B+1.41%
Q4 202333.30M$2.7B+1.71%
Q3 202333.53M$2.5B+1.69%
Q2 202333.98M$2.6B+1.75%
Q1 202334.70M$2.9B+1.96%
Q4 202235.89M$3.1B+2.11%
Q3 202236.37M$2.2B+1.70%
Q2 202236.97M$2.3B+1.58%
Q1 202237.03M$2.2B+1.34%
Q4 202137.17M$2.7B+1.67%
Q3 202137.27M$2.6B+1.70%
Q2 202128.96M$2.0B+1.30%
Q1 202118.46M$1.2B+0.85%
Q4 202017.11M$997M+0.79%
Q3 202012.61M$797M+0.73%
Q2 202012.59M$969M+0.89%
Q1 202015.11M$1.1B+1.22%
Q4 201917.45M$1.1B+0.87%
Q3 201917.44M$1.1B+0.91%
Q2 201917.23M$1.2B+0.94%
Q1 201917.07M$1.1B+0.91%
Q4 201816.52M$1.0B+0.95%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Dodge & Cox’s full portfolio or all institutional holders of GILD.